Drug Discovery & DevelopmentASCO: Trial Undermines Surrogate MarkersMedPage TodayOncology/Hematology. ASCO: Trial Undermines Surrogate Markers. Published: Jun 2, 2014. By Michael Smith, North American Correspondent, MedPage Today. save. |. A. A. Post Test Complete · Take Posttest. Action Points. Note that this randomized trial of …GSK Breast Cancer Drug Misses Endpoint in Phase 3Drug Discovery & DevelopmentGSK’s Phase III trial of breast cancer combination treatment fails to meet primary …Pharmaceutical Business ReviewASCO 2014: Phase III ALTTO disappointing, but may set new tenor for pCR in …BioWorld OnlineThe Pharma Letterall 12 news articles …Read Full Story
ASCO: Trial Undermines Surrogate Markers - MedPage Today
Real Estate of Cebu
